Description

59,71,920 equity shares of BANDARAM PHARMA PACKTECH LIMITED listed on BSE with effect from December 16, 2025, issued on preferential basis to promoters and non-promoters.

Summary

BSE has approved the listing of 59,71,920 new equity shares of BANDARAM PHARMA PACKTECH LIMITED (Scrip Code: 524602) with effect from December 16, 2025. These shares were issued at Rs. 20/- per share (face value Rs. 10/- plus premium of Rs. 10/-) on a preferential basis to promoters and non-promoters. The allotment date was November 6, 2025, and the shares are subject to lock-in periods.

Key Points

  • Total new shares listed: 59,71,920 equity shares of Rs. 10/- each
  • Issue price: Rs. 20/- per share (including premium of Rs. 10/-)
  • Scrip Code: 524602
  • ISIN: INE875N01036
  • Trading commencement date: December 16, 2025
  • Date of allotment: November 6, 2025
  • Shares rank pari-passu with existing equity shares
  • Distinctive Numbers: 12000001 to 17971920

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification following preferential allotment procedures.

Compliance Requirements

  • Trading members must note the new securities for trading from December 16, 2025
  • Lock-in restrictions apply to all shares:
    • 22,54,484 shares (Dist. Nos. 12000001 - 14254484): Locked-in until June 30, 2027
    • 37,17,436 shares (Dist. Nos. 14254485 - 17971920): Locked-in until June 30, 2026

Important Dates

  • Allotment Date: November 6, 2025
  • Trading Commencement: December 16, 2025
  • Lock-in Expiry (Partial): June 30, 2026 (for 37,17,436 shares)
  • Lock-in Expiry (Balance): June 30, 2027 (for 22,54,484 shares)

Impact Assessment

The listing represents a capital raise through preferential allotment for BANDARAM PHARMA PACKTECH LIMITED. With approximately 59.72 lakh new shares entering the market (subject to lock-in), this will increase the company’s equity base. The staggered lock-in periods (2026 and 2027) will delay the free float of these shares. Market impact is expected to be minimal as shares are locked-in and the issuance is company-specific. Trading members should update their systems to reflect the new share capital and lock-in details.

Impact Justification

Routine preferential allotment listing with standard lock-in provisions. Limited market-wide impact as it affects only one company's shares.